Post Concurrent Chemoradiation Therapy: Management of Patients Who Do Not Progress

Learn from Dr Mark Socinski on potential treatment for eligible patients with
unresectable Stage III non-small cell lung cancer (NSCLC) who have not progressed after concurrent chemoradiation and helping to manage potential adverse events associated with the treatment.